Taipei's biotech sector made a notable impression at the 2024 BIO International Convention, with an impressive 145 partnering sessions held and attracted participants from over 30 countries around the world, underscoring the remarkable achievements of Taipei's biotech industry. This successful showing highlights Taipei's prominent position in the global biotechnology landscape.
The Taipei City Government, along with six leading Taipei-based biotech companies—Oneness Biotech, TAHO Pharmaceuticals, BIONET Corp., Hughes Biotechnology, QT Medical, and Origin Biotechnology—showcased their latest technological innovations at this prestigious global event. Their cutting-edge products drew significant international interest.

The Department of Economic Development noted that since 2019, the city government has been actively promoting Taipei's biotechnology enterprises at international exhibitions. So far, 36 biotech companies have been showcased globally, highlighting their cutting-edge technologies and products. Through global exhibitions and one-on-one partnering meetings, these companies have significantly boosted their international visibility, leading to over 600 partnering sessions. This initiative has been a crucial stepping stone for Taipei's biotech firms to enter and succeed in international markets.
The Taipei Exhibition area at the 2024 BIO International Convention features a diverse array of cutting-edge technological products. In applied biotechnology, highlights include BIONET Corp., Taiwan’s first publicly listed cell therapy company, and Hughes Biotechnology, which uses “precursor drugs” to innovate health foods by making insoluble substances soluble, creating new health opportunities.
In the medical devices sector, QT Medical presents its medical-grade “PCA 500 12-lead ECG system” for use in aviation emergency medicine, remote consultations, home care, and more. Meanwhile, Origin Biotechnology showcases genetic molecular detection reagents for conditions like spinal muscular atrophy, offering quick and accurate screenings for women and children.

In pharmaceuticals, TAHO Pharmaceuticals utilizes its proprietary Transepithelial Delivery System (TDS) to develop drugs of different dosage forms in the fields of cardiovascular diseases, central nervous system diseases, and cancer hospice care.Oneness Biotech, the first Taiwanese biotech company included in the 2023 Dow Jones Sustainability Index, is displaying its innovative products “Fespixon”, “Bonvadis” and “FB825” (anti-IgE mAb) as it aims to break into the international market.These exhibitors highlight the impressive diversity and strength of Taipei’s biotechnology sector, demonstrating its robust capabilities on the global stage.

The Department of Economic Development has highlighted that Taipei's biotechnology industry is set for global expansion. Beyond the BIO International Convention, the Taipei City Government will establish a Taipei Biotech Pavilion and participate in BIO ASIA in July. Additionally, in November, it will lead the city's biomedical companies to MEDICA in Germany for the first time. This active international exposure aims to attract global attention, create business opportunities, and build the international brand of Taipei biotechnology.